Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cytek BioSciences

3.31
+0.09002.80%
Volume:1.06M
Turnover:3.46M
Market Cap:419.24M
PE:-37.29
High:3.35
Open:3.26
Low:3.17
Close:3.22
Loading ...

Cytek Biosciences CFO William D. McCombe Reports Acquisition of Common Shares

Reuters
·
04 Jun

Cytek Biosciences Unveils Revolutionary Aurora Evo System, Enhancing High-Throughput Capabilities in Spectral Flow Cytometry

Reuters
·
30 May

Cytek Biosciences Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
29 May

Cytek Biosciences price target lowered to $4 from $6 at Stephens

TIPRANKS
·
16 May

Cytek Biosciences (CTKB) Gets a Buy from Piper Sandler

TIPRANKS
·
16 May

Cytek Biosciences Is Maintained at Sell by Goldman Sachs

Dow Jones
·
13 May

Piper Sandler Sticks to Its Buy Rating for Cytek Biosciences (CTKB)

TIPRANKS
·
09 May

Cytek Biosciences Inc : TD Cowen Cuts to Hold From Buy; Cuts Target Price to $4 From $7

THOMSON REUTERS
·
09 May

TD Cowen Downgrades Cytek Biosciences to Hold From Buy, Adjusts Price Target to $4 From $7

MT Newswires Live
·
09 May

Cytek Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

Cytek Biosciences Q1 EPS $(0.09) Misses $(0.04) Estimate, Sales $51.93M Beat $42.66M Estimate

Benzinga
·
09 May

Cytek Biosciences Reports Q1 2025 Revenue Drop of 7.6% and Adjusted EBITDA Loss of $5.5 Million

Reuters
·
09 May

BRIEF-Cytek Biosciences Q1 Revenue USD 41.457 Million Vs. IBES Estimate USD 42.7 Million

Reuters
·
09 May

Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025

GlobeNewswire
·
30 Apr

Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025

GlobeNewswire
·
25 Apr

Cytek Biosciences Price Target Maintained With a $6.00/Share by Stephens & Co.

Dow Jones
·
19 Mar

Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System

GlobeNewswire
·
19 Mar

Open Lending Leads Our Trio Of Promising Penny Stocks

Simply Wall St.
·
11 Mar

Cytek Biosciences, Inc. (CTKB): Why Are Hedge Funds Bullish On This Cash-Rich Penny Stock?

Insider Monkey
·
08 Mar

Cytek Biosciences Is Maintained at Overweight by Piper Sandler

Dow Jones
·
04 Mar